| Application no. and date | 14721834.1 (espacenet) (Federated) (European Patent Register), 20140502 | | Patent/reg. no. and date | DK/EP 2991671, 20180815 | | Publication date | 20160309 | | Priority no. and date | EP 13166205, 20130502 | | EP pub. no. and date |
EP 2991671 20160309 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P65802DK01 | | Inventor | SAUERBERG, Per, Novo Allé, 2880 Bagsværd, DK,
NIELSEN, Flemming Seier, Novo Allé, 2880 Bagsværd, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 3/10 (2006.01) | | Title | ORAL DOSERING AF GLP-1-FORBINDELSER | | Int. application no. | EP2014058974 | | Int. publication no. | WO2014177683 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
